- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x 01: (R)-amino-3-hydroxybutanoic acid
01.1: 10 residues within 4Å:- Chain A: E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain B: Y.123, R.125, M.177, S.189
8 PLIP interactions:4 interactions with chain A, 4 interactions with chain B- Hydrogen bonds: A:E.217, A:S.218, A:T.265, A:T.265, B:S.189, B:S.189
- Hydrophobic interactions: B:Y.123
- Salt bridges: B:R.125
01.13: 10 residues within 4Å:- Chain B: E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain C: Y.123, R.125, M.177, S.189
8 PLIP interactions:4 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:Y.123
- Hydrogen bonds: C:S.189, C:S.189, B:E.217, B:S.218, B:T.265, B:T.265
- Salt bridges: C:R.125
01.24: 10 residues within 4Å:- Chain C: E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain D: Y.123, R.125, M.177, S.189
8 PLIP interactions:4 interactions with chain D, 4 interactions with chain C- Hydrophobic interactions: D:Y.123
- Hydrogen bonds: D:S.189, D:S.189, C:E.217, C:S.218, C:T.265, C:T.265
- Salt bridges: D:R.125
01.35: 10 residues within 4Å:- Chain D: E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain E: Y.123, R.125, M.177, S.189
8 PLIP interactions:4 interactions with chain D, 4 interactions with chain E- Hydrogen bonds: D:E.217, D:S.218, D:T.265, D:T.265, E:S.189, E:S.189
- Hydrophobic interactions: E:Y.123
- Salt bridges: E:R.125
01.48: 10 residues within 4Å:- Chain A: Y.123, R.125, M.177, S.189
- Chain E: E.217, S.218, Y.219, Y.262, T.265, Y.268
8 PLIP interactions:4 interactions with chain A, 4 interactions with chain E- Hydrophobic interactions: A:Y.123
- Hydrogen bonds: A:S.189, A:S.189, E:E.217, E:S.218, E:T.265, E:T.265
- Salt bridges: A:R.125
- 10 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 25 x OCT: N-OCTANE(Non-covalent)
OCT.4: 3 residues within 4Å:- Chain A: W.304
- Chain E: Y.367, L.368
Ligand excluded by PLIPOCT.5: 3 residues within 4Å:- Chain A: Y.289, F.290, T.293
Ligand excluded by PLIPOCT.8: 2 residues within 4Å:- Chain A: I.455, S.459
Ligand excluded by PLIPOCT.10: 2 residues within 4Å:- Chain A: V.353
- Chain B: L.286
Ligand excluded by PLIPOCT.11: 2 residues within 4Å:- Chain A: I.473, I.477
Ligand excluded by PLIPOCT.16: 2 residues within 4Å:- Chain A: Y.367
- Chain B: W.304
Ligand excluded by PLIPOCT.17: 3 residues within 4Å:- Chain B: Y.289, F.290, T.293
Ligand excluded by PLIPOCT.20: 2 residues within 4Å:- Chain B: I.455, S.459
Ligand excluded by PLIPOCT.22: 2 residues within 4Å:- Chain B: V.353
- Chain C: L.286
Ligand excluded by PLIPOCT.23: 2 residues within 4Å:- Chain B: I.473, I.477
Ligand excluded by PLIPOCT.27: 3 residues within 4Å:- Chain B: Y.367, L.368
- Chain C: W.304
Ligand excluded by PLIPOCT.28: 3 residues within 4Å:- Chain C: Y.289, F.290, T.293
Ligand excluded by PLIPOCT.31: 2 residues within 4Å:- Chain C: I.455, S.459
Ligand excluded by PLIPOCT.33: 2 residues within 4Å:- Chain C: V.353
- Chain D: L.286
Ligand excluded by PLIPOCT.34: 2 residues within 4Å:- Chain C: I.473, I.477
Ligand excluded by PLIPOCT.38: 3 residues within 4Å:- Chain C: Y.367, L.368
- Chain D: W.304
Ligand excluded by PLIPOCT.39: 3 residues within 4Å:- Chain D: Y.289, F.290, T.293
Ligand excluded by PLIPOCT.42: 2 residues within 4Å:- Chain D: I.455, S.459
Ligand excluded by PLIPOCT.44: 2 residues within 4Å:- Chain D: V.353
- Chain E: L.286
Ligand excluded by PLIPOCT.45: 2 residues within 4Å:- Chain D: I.473, I.477
Ligand excluded by PLIPOCT.46: 3 residues within 4Å:- Chain A: L.286
- Chain E: W.349, V.353
Ligand excluded by PLIPOCT.47: 3 residues within 4Å:- Chain E: I.346, I.473, I.477
Ligand excluded by PLIPOCT.51: 3 residues within 4Å:- Chain D: Y.367, L.368
- Chain E: W.304
Ligand excluded by PLIPOCT.52: 3 residues within 4Å:- Chain E: Y.289, F.290, T.293
Ligand excluded by PLIPOCT.55: 2 residues within 4Å:- Chain E: I.455, S.459
Ligand excluded by PLIP- 15 x HEX: HEXANE(Non-covalent)(Non-functional Binders)
HEX.6: 2 residues within 4Å:- Chain A: W.475, S.479
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:W.475, A:W.475, A:W.475
HEX.7: 2 residues within 4Å:- Chain A: W.304, R.460
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:W.304
HEX.9: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)HEX.18: 2 residues within 4Å:- Chain B: W.475, S.479
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:W.475, B:W.475, B:W.475
HEX.19: 2 residues within 4Å:- Chain B: W.304, R.460
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:W.304
HEX.21: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)HEX.29: 2 residues within 4Å:- Chain C: W.475, S.479
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:W.475, C:W.475, C:W.475
HEX.30: 2 residues within 4Å:- Chain C: W.304, R.460
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:W.304
HEX.32: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)HEX.40: 2 residues within 4Å:- Chain D: W.475, S.479
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:W.475, D:W.475, D:W.475
HEX.41: 2 residues within 4Å:- Chain D: W.304, R.460
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:W.304
HEX.43: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)HEX.53: 2 residues within 4Å:- Chain E: W.475, S.479
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:W.475, E:W.475, E:W.475
HEX.54: 2 residues within 4Å:- Chain E: W.304, R.460
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:W.304
HEX.56: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fan, C. et al., Cryo-EM structures of Rho1 GABAA receptors with antagonist and agonist drugs. To Be Published
- Release Date
- 2025-07-02
- Peptides
- Gamma-aminobutyric acid receptor subunit rho-1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x 01: (R)-amino-3-hydroxybutanoic acid
- 10 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 25 x OCT: N-OCTANE(Non-covalent)
- 15 x HEX: HEXANE(Non-covalent)(Non-functional Binders)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fan, C. et al., Cryo-EM structures of Rho1 GABAA receptors with antagonist and agonist drugs. To Be Published
- Release Date
- 2025-07-02
- Peptides
- Gamma-aminobutyric acid receptor subunit rho-1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.